BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37802701)

  • 41. Factors predicting ablation site recurrence following percutaneous microwave ablation of colorectal hepatic metastases.
    Urbonas T; Anderson EM; Gordon-Weeks AN; Kabir SI; Soonawalla Z; Silva MA; Gleeson FV; Reddy S
    HPB (Oxford); 2019 Sep; 21(9):1175-1184. PubMed ID: 30777696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone.
    Dai Y; Zhang Y; He W; Peng C; Qiu J; Zheng N; Li H; Liu W; Zheng Y; Li B; Yuan Y; Zou R
    Int J Hyperthermia; 2021; 38(1):372-381. PubMed ID: 33657952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA).
    Nour-Eldin NA; Exner S; Al-Subhi M; Naguib NNN; Kaltenbach B; Roman A; Vogl TJ
    Int J Hyperthermia; 2017 Nov; 33(7):820-829. PubMed ID: 28540791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical debulking is associated with improved survival for patients with neuroendocrine liver metastases of unknown primary.
    Ruff SM; Thompson DA; Lad NL; Anantha S; DePeralta DK; Weiss MJ; Deutsch GB
    HPB (Oxford); 2023 Sep; 25(9):1074-1082. PubMed ID: 37258312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach.
    Nadler A; Cukier M; Milot L; Singh S; Law CH
    Can J Surg; 2014 Apr; 57(2):E2-8. PubMed ID: 24666455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma liver metastases with special imaging features on magnetic resonance imaging after microwave ablations: How to evaluate technical efficacy?
    Cao F; Xie L; Qi H; Ze S; Chen S; Shen L; Zhang X; Fan W
    J Cancer Res Ther; 2019; 15(7):1501-1507. PubMed ID: 31939429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Neuroendocrine Liver Metastases.
    Farley HA; Pommier RF
    Surg Oncol Clin N Am; 2016 Jan; 25(1):217-25. PubMed ID: 26610783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microwave ablation versus resection for colorectal cancer liver metastases - A propensity score analysis from a population-based nationwide registry.
    Tinguely P; Dal G; Bottai M; Nilsson H; Freedman J; Engstrand J
    Eur J Surg Oncol; 2020 Mar; 46(3):476-485. PubMed ID: 31837931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
    Danışan G; Küpeli A; Taydaş O
    Turk J Med Sci; 2022 Aug; 52(4):1336-1343. PubMed ID: 36326409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    HPB (Oxford); 2020 Mar; 22(3):461-469. PubMed ID: 31473076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
    Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
    Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
    van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases.
    Banz VM; Baechtold M; Weber S; Peterhans M; Inderbitzin D; Candinas D
    World J Gastroenterol; 2014 Oct; 20(40):14992-6. PubMed ID: 25356061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Karagkounis G; McIntyre SM; Wang T; Chou JF; Nasar N; Gonen M; Balachandran VP; Wei AC; Soares KC; Drebin JA; D'Angelica MI; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2023 Oct; 30(11):6571-6578. PubMed ID: 37365414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of ablation algorithm versus tumor-dependent parameters on local control after microwave ablation of malignant liver tumors.
    Erten O; Li P; Gokceimam M; Akbulut S; Berber E
    J Surg Oncol; 2021 Jan; 123(1):179-186. PubMed ID: 32976655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
    Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
    Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM
    J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.